Haas, M, Hall, J, Viney, R, Gallego, G. Breaking up is hard to do: Why disinvestment in medical technology is harder than investment. Aust Health Rev. 2012;36:148–152.
Joshi, NP, Stahnish, FW, Noseworth, TW. Reassessment of health technologies: Obsolescence and waste. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH); 2009.
Center for Clinical Effectiveness. Health technology disinvestment: Tests, drugs and clinical practice. Report on a national disinvestment workshop. Melbourne, Australia: Center for Clinical Effectiveness; 2009.
Mc Kean, G, Noseworthy, T, Elshaug, A, Clement, F. Health technology reassessment: The art of the possible. Int J Technol Assess Health Care. 2013;29:418–423.
CHERE. Reducing the use of ineffective health care interventions. Centre for Health Economics Research and Evaluation, 2010. Working Paper 2010/5.
Leggett, L, Noseworthy, TW, Zarrabi, M, et al.
Health technology reassessment of non-drug technologies: Current practices. Int J Technol Assess Health Care. 2012;28:220–227.
Gerdvilaite, J, Nachtnebel, A. Disinvestment. Overview of disinvestment experiences and challenges in selected countries. Vienna: Ludwig Boltzmann Institut for Health Technology Assessment (LBI HTA); 2011.
Garner, S, Littlejohns, P. Disinvestment from low value clinical interventions: NICEly done? BMJ. 2011;343:d4519.
Elshaug, AG, Hiller, JE, Tunis, SR, Moss, JR. Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices. Aust New Zealand Health Policy. 2007;4:23.
Henshall, C, Schuller, T, Mardhani-Bayne, L. Using health technology assessment to support optimal use of technologies in current practice: The challenge of “disinvestment”. Int J Technol Assess Health Care. 2012;28:203–210.
Haines, T, O’Brien, L, McDermott, F, et al.
A novel research design can aid disinvestment from existing health technologies with uncertain effectiveness, cost-effectiveness, and/or safety. J Clin Epidemiol. 2014;67:144–51.
Elshaug, AG, McWilliams, JM, Landon, BE. The value of low-value lists. JAMA. 2013;309:775–776.
Howard, DH, Shen, Y-C. Comparative effectiveness research, technological abandonment, and health care spending. Adv Health Econ Health Serv Res. 2012;23:103–121.
Scott, IA, Elshaug, AG. Foregoing low-value care: How much evidence is needed to change beliefs? Intern Med J. 2013;43:107–109.
Victorian Government Department of Human Services. Future directions for health technology uptake, diffussion and disinvestment in Victorian public health services. Workshop discussion paper. Melbourne, Australia: Victorian Government Department of Human Services; 2007.
Ibargoyen-Roteta, N, Gutierrez-Ibarluzea, I, Asua, J. Report on the development of the GuNFT guideline. Guideline for not funding existing health technologies in health care systems. Vitoria-Gasteiz: Basque Office for Health Technology Assessment Health Department Basque Government (OSTEBA); 2009.
Atienza Merino, G, Varela Lema, L. Needs and demands of policy-makers. In: Velasco, Garrido M, Børlum, Kristensen F, Palmhøj, Nielsen C, Busse, R, eds. Health technology assessment and health policy-making in Europe Current status, challenges and potential. Geneva: World Health Organization; 2008.
Mitton, C. Questionnaire: Identifying models and strategies for optimal resource allocation and disinvestment in health care systems- Focus on PBMA. 2013.
Mitton, C, Dionne, F, Damji, R, Campbell, D, Bryan, S. Difficult decisions in times of constraint: Criteria based resource allocation in the Vancouver Coastal Health Authority. BMC Health Serv Res. 2011;11:169.
Chamberlain, CA, Martin, RM, Busby, J, et al.
Trends in procedures for infertility and caesarean sections: Was NICE disinvestment guidance implemented? NICE recommendation reminders. BMC Public Health. 2013;13:112.
Lavis, JN, Røttingen, J-A, Bosch-Capblanch, X, et al.
Guidance for evidence-informed policies about health systems: Linking guidance development to policy development. PLoS Med. 2012;9:e1001186.